Medical Tourism Blog

Procedure

HPV Vaccine Gardasil 9 in Korea: Eligibility, Dose Schedule, Travel Planning, and Aftercare

HPV Vaccine Gardasil 9 in Korea: Eligibility, Dose Schedule, Travel Planning, and Aftercare
Friday, Sep 18, 2026

Table of contents

Considering treatment in Korea? Everything you need to know e.g. β€” how to avoid scams, visas, interpreters, recovery tips β€” in our Medical Tourism Master Guide. Plan with confidence in minutes, not weeks!


Last updated: September 2026

HPV Vaccine Gardasil 9 at a Glance

  • What it involves β€” Gardasil 9 is a preventive, noninfectious vaccine given as a 0.5 mL injection into the upper-arm deltoid; it covers nine HPV types and cannot cause HPV infection.
  • Cost per dose β€” The listed Korea price is KRW 520,000 (about USD 400) per dose; confirm whether screening, 15-minute observation, and an English vaccination certificate are included.
  • Dose schedule β€” Those starting at ages 9–14 receive 2 doses at month 0 and 6–12 months, while Korean guidance lists 3 doses at months 0, 2, and 6 for women aged 15–45 and men aged 15–26.
  • One-day visit, ongoing series β€” Screening, injection, and the required 15-minute observation are usually completed in one day, but a short Korea trip cannot complete the multi-month series; arrange later doses at home.
  • Minimal recovery β€” No surgical recovery or activity restriction is expected; arm soreness, fatigue, headache, low-grade fever, dizziness, or nausea may occur and generally settle within a few days.
  • Key limitation β€” Gardasil 9 prevents new infections from covered HPV types but does not clear an existing HPV infection or treat genital warts, abnormal screening results, precancer, or cancer.
  • Korea eligibility distinction β€” Korean product information lists Gardasil 9 for women through age 45 but men only through age 26, so male travelers aged 27–45 need written confirmation of clinic eligibility before travel.

What Is Gardasil 9 HPV Vaccination?

Gardasil 9 is a vaccine that helps prevent infection from nine types of human papillomavirus (HPV). It supports prevention of HPV-related cancers, precancers, and genital warts caused by covered types, but does not treat existing HPV infection or disease. It is a non-surgical preventive immunization given by injection.

Who Is a Good Candidate for Gardasil 9 HPV Vaccination?

  • People starting the HPV vaccine series β€” Korean guidance lists Gardasil 9 for girls and women aged 9–45 and boys and men aged 9–26. The schedule is based on age when the series begins.
  • Ages 9–14 at first dose β€” A 2-dose course is listed, with doses at month 0 and 6–12 months.
  • Women aged 15–45 and men aged 15–26 β€” A 3-dose course is listed at months 0, 2, and 6.
  • People with prior sexual activity or HPV history β€” Vaccination can still be discussed with a longitudinal-care clinician; prior exposure does not establish exposure to every vaccine-covered type. Gardasil 9 is preventive and does not clear an existing infection or treat warts, abnormal screening results, precancer, or cancer.
  • Travelers able to arrange later doses β€” The preventive endpoint is completing the indicated series, so short-term visitors need a reliable plan and written record for doses at home.

Do not receive Gardasil 9 after anaphylaxis or another severe allergic reaction to a previous Gardasil 9 or quadrivalent Gardasil dose, a vaccine component, or baker’s yeast (Saccharomyces cerevisiae). Defer vaccination during a moderate or severe acute illness, but a minor illness generally does not require delay. Defer routine vaccination during a known pregnancy and complete outstanding doses after pregnancy; pregnancy testing solely for HPV vaccination is not required. Men aged 27–45 should obtain written confirmation before travel: Korean product information lists men through age 26, even where guidance in their home country differs. Immune conditions, HIV, cancer treatment, transplant history, anticoagulant use, antiplatelet treatment, thrombocytopenia, and bleeding disorders require an individualized assessment but do not automatically rule out intramuscular vaccination.


How Is Gardasil 9 HPV Vaccination Performed?

There is no surgical technique or cosmetic-treatment variation. The practical distinctions are the age-based dose schedule and continuity of a multi-month series.

  • 2-dose schedule β€” Korean KDCA guidance lists doses at month 0 and 6–12 months for girls and boys who start at ages 9–14.
  • 3-dose schedule β€” The same guidance lists doses at months 0, 2, and 6 for women aged 15–45 and men aged 15–26.
  • Standard administration β€” A clinician gives 0.5 mL intramuscularly into the deltoid, the upper-arm muscle.
  • Vaccine composition β€” Gardasil 9 is a recombinant, noninfectious virus-like-particle vaccine covering HPV types 6, 11, 16, 18, 31, 33, 45, 52, and 58; it cannot cause HPV infection.

Why Visit Korea for Gardasil 9 HPV Vaccination?

Labia Minora Whitening, Labia Majora Whitening, Labiaplasty, Laser Labiaplasty, Revision Labiaplasty, Vaginal Tightening Laser, Vaginoplasty, Vaginal Bleaching, Vaginal Filler, Vaginal Implant, Vaginal Dryness, Ovarian Cancer Screening, HPV Vaccine Gardasil 9, PRP Vaginal Rejuvenation, Petit Vaginal Plastic Surgery, Laser Vaginal Rejuvenation

A Gardasil 9 dose in Korea is not biologically superior to the same authentic vaccine given appropriately elsewhere. For international patients, the defensible reasons to receive a dose in Korea are access during an existing trip and the ability to obtain a documented vaccination visit. Confirm product stock, eligibility, price, language support, and documentation standards directly with the intended facility before booking travel.

  • Published local schedule β€” KDCA guidance specifies the 0.5 mL deltoid dose and Korean age-based 2-dose and 3-dose schedules.
  • Clear local eligibility boundary β€” Korean MFDS-sourced product information lists women through age 45 and men through age 26, an important distinction for male travelers aged 27–45 who must not assume access under a Korean facility’s policy.
  • Private-care planning is essential β€” Gardasil 9 is not included in Korea’s national HPV immunization support program, which identifies quadrivalent Gardasil and bivalent Cervarix for specified supported populations. Public-program information does not confirm private-clinic inventory or visitor eligibility.
  • Record continuity β€” A Korean visit can provide a detailed record for later doses abroad, but only if the facility can issue it in English with the product, date, dose, lot number, injection site, provider, and contact details.

Key Information for International Patients

  • Minimum stay β€” One dose, screening, injection, and the required post-vaccination observation can usually be completed in one day. Allow an extra day when itinerary flexibility is important or when short-lived fever, fatigue, dizziness, or arm soreness would disrupt plans.
  • Repeat visits β€” A conventional short trip cannot complete the series. Korean guidance uses month 0 and 6–12 for the 2-dose course, or months 0, 2, and 6 for the applicable 3-dose course; arrange later doses with a clinician at home.
  • Flight timing β€” There is no formal flight restriction after an uncomplicated dose and observation period. Avoid placing the injection immediately before a long-haul departure when possible, so medical assessment remains accessible if faintness, fever, or an allergic reaction occurs.
  • Activity and itinerary β€” No surgical recovery, accommodation change, or companion is required solely for vaccination. Resume ordinary activity after observation when feeling well; account for possible arm pain, headache, fatigue, or low-grade fever for several days.
  • Remote continuity β€” Send the Korean vaccination record to the clinician managing the series at home. Keep original and digital copies rather than relying on a verbal history.

Travel note: Ask in writing before travel whether the facility has Gardasil 9 in stock, will vaccinate a nonresident of your age and sex, can communicate in English or arrange interpretation, and can provide a complete English vaccination certificate.


Which Are the Best Clinics in Korea for Hpv Vaccine Gardasil 9?

Listed below are some of the best clinics in Korea for hpv vaccine gardasil 9.

1. SH Clinic

If you are exploring Gardasil 9 vaccination alongside women’s health care in Seoul, SH Clinic offers a gynecology-focused setting where care is performed by an experienced board-certified gynecologist. Its provided information confirms cervical cancer screening with HPV testing, although it does not specifically confirm Gardasil 9 vaccination availability.

  • URL: SH Clinic Website
  • Location: Seocho-gu, Seoul
  • Women’s health care:
    • Cervical and ovarian cancer screening services include Pap smears, HPV testing, and ultrasound.
    • The clinic provides general gynecological care as well as treatment for concerns such as urinary incontinence.
  • Clinician information: Procedures are stated to be performed directly by a board-certified gynecologist who has received a commendation from the Minister of Health and Welfare.

2. Highst Urology Clinic

Highst Urology Clinic provides urology-focused evaluation and treatment for urinary and male reproductive health in Nonhyeon. The available information does not confirm that Gardasil 9 vaccination is offered, so you should verify vaccine availability and scheduling directly with the clinic.

3. Personal Beauty GU Clinic Ilsan

At Personal Beauty GU Clinic Ilsan, you can receive the 9-strain Gardasil HPV vaccine, which is described as protecting against nine HPV strains. The clinic also offers a broad range of dermatology and aesthetic services, should you be coordinating other non-surgical treatments during your visit.

  • URL: Personal Beauty GU Clinic Ilsan Website
  • Location: Ilsandong-gu, Goyang-si, Gyeonggi
  • Procedure details:
    • The clinic lists a 9-strain Gardasil vaccine for HPV vaccination.
    • The provided information describes the vaccine as offering protection against nine HPV strains.
  • Other available services:
    • Dermatology offerings include laser lifting, Botox, fillers, skin boosters, pigment treatments, scar and pore management, and hair removal.
    • Available devices and technologies listed include Ulthera, Thermage, Tune Face, Shurink Universe, and Gentle Max Pro.

How Much Does Gardasil 9 HPV Vaccination Cost in Korea?

Gardasil 9 HPV vaccination is listed at KRW 520,000 (approximately USD 400) per supplied price range. Individual quotes vary because the required vaccine-series schedule and the extent of pre-vaccination assessment can differ.

Procedure PriceKorean Won (β‚©)USD ($)
Low Priceβ‚©520,000$400
High Priceβ‚©520,000$400

Exchange rate as of 2026-09-06: 1 KRW = 0.000741 USD.

What Affects the Price?

  • Number of Gardasil 9 doses required β€” Korean guidance uses a 2-dose course for those starting at ages 9–14 and a 3-dose course for applicable older patients. Each additional dose requires another 0.5 mL vaccine supply, injection visit, screening, and post-vaccination observation, so the full-series outlay differs from the cost of one dose.
  • Prior-dose record review and series planning β€” A clinician may need to verify prior HPV vaccine product names and dates to determine whether the visit is a first dose, a continuation dose, or requires an individualized plan. This adds consultation time and is particularly important when later doses will be completed in another country.
  • Clinical assessment for precautions β€” Pregnancy, moderate or severe acute illness, severe allergy history, immune conditions, bleeding disorders, and anticoagulant or antiplatelet use require focused screening before an intramuscular deltoid injection. These requirements can add consultation and monitoring resources beyond a routine vaccination visit.

Cost tip: Request an itemized quote stating what is included, including the Gardasil 9 dose, screening consultation, injection, required post-vaccination observation, and vaccination documentation.

The USD 400 conversion is approximate, based on the supplied exchange rate dated 2026-09-06. Check the exchange rate again when budgeting.


HPV Vaccine Gardasil 9 From Start to Finish

  1. First contact and record review β€” Contact the facility before travel to confirm Gardasil 9 stock, eligibility, appointment availability, language or interpreter arrangements, and documentation. Send prior HPV vaccine dates, product names, and records of vaccine reactions.
  2. Travel coordination β€” Plan the visit early in the stay rather than just before a long-haul flight. Establish which clinician at home will manage later doses in the series.
  3. Screening consultation β€” The clinician reviews prior doses, allergies including yeast hypersensitivity, pregnancy status, current illness, immune history, bleeding risk, and medicines. A routine HPV DNA test, Pap test, pelvic examination, blood test, fasting, or pregnancy test is not required solely for a standard dose.
  4. Dose-plan confirmation β€” The clinician confirms whether the visit is dose 1, 2, or 3 and documents the intended schedule. Do not assume that an incomplete or delayed series must be restarted; have the clinician assess the prior product and dates.
  5. Injection β€” The provider administers 0.5 mL of Gardasil 9 intramuscularly in the deltoid. No anesthesia or sedation is needed.
  6. Observation and discharge β€” Remain seated or lying down in the clinic for at least 15 minutes because fainting can occur after vaccination and can cause fall injuries. Leave when well and after staff discharge.
  7. Documentation and overseas follow-up β€” Obtain an English record containing the brand, nine-valent formulation, date, 0.5 mL dose, lot or batch number, injection site, provider name, and facility contact details. Share it with the clinician arranging future doses and contact the Korean facility promptly if a post-dose concern develops while still in the country.

Alternatives to Gardasil 9 HPV Vaccination

Other HPV vaccines can provide narrower type coverage, while screening identifies cervical abnormalities rather than preventing HPV infection. Neither is a like-for-like substitute for Gardasil 9’s nine-type coverage. Vaccination also does not replace recommended screening or treatment for established HPV-related disease.

Quadrivalent Gardasil

  • Coverage tradeoff β€” Protects against HPV types 6, 11, 16, and 18, but not the additional Gardasil 9 types 31, 33, 45, 52, and 58.
  • Korean access context β€” Quadrivalent Gardasil is identified in Korea’s national HPV support program for specified eligible groups; that does not establish eligibility for a visitor.

Bivalent Cervarix

  • Coverage tradeoff β€” Targets HPV types 16 and 18 and does not provide Gardasil 9’s coverage for types 6 and 11 associated principally with genital warts or for the additional five high-risk types.
  • Korean access context β€” Cervarix is also named in the national support program for specified populations, not as a coverage-equivalent replacement for Gardasil 9.

Cervical Cancer Screening

  • Different purpose β€” Cervical screening detects abnormalities and does not prevent a new HPV infection. People with a cervix should continue screening according to the guidance and risk profile applicable where they receive ongoing care.
  • Established disease β€” Genital warts, abnormal HPV or Pap results, precancer, and cancer require condition-specific evaluation and treatment; Gardasil 9 does not treat these conditions.

How Can I Prepare for Gardasil 9 HPV Vaccination?

  • Confirm eligibility and stock β€” Obtain written confirmation of product availability, appointment timing, facility policy for visitors, and eligibility before booking nonrefundable travel, especially for men aged 27–45.
  • Bring vaccine records β€” Carry records showing each previous HPV product, dose date, and documented vaccine reaction. Bring paper copies and secure digital copies.
  • Disclose relevant history β€” Report severe allergies, yeast allergy, pregnancy or pregnancy plans, moderate or severe current illness, immune conditions including HIV, cancer treatment, transplant history, bleeding disorders, and all medicines.
  • Do not stop prescribed medicines independently β€” Do not discontinue anticoagulants, antiplatelets, immunosuppressants, or other prescription drugs solely for vaccination. Tell the vaccinator about them in advance; bleeding risk can require injection-site pressure and technique adjustments.
  • Eat, hydrate, and dress practically β€” No fasting is required. Eat and drink normally, wear a short-sleeved or loose top for deltoid access, and tell staff about needle anxiety or a previous fainting episode.
  • Plan transport and companions realistically β€” No companion or recovery hotel is routinely needed. Bring a companion for a minor, significant needle anxiety, or a history of fainting; avoid driving immediately if dizzy after the injection.

Travel note: Schedule the dose with enough time before a long-haul departure to complete the 15-minute observation period and manage short-lived symptoms without airport pressure.

Confirm the treating doctor’s clinic-specific requirements; their individualized instructions take precedence over this general guidance.


Aftercare Advice

Complete the observation period, protect against a fainting-related fall, and treat new severe allergic symptoms as an emergency.

  • Observation β€” Stay in the clinic for at least 15 minutes after injection. Sit or lie down if lightheaded, nauseated, sweaty, or faint, and alert staff immediately.
  • Normal activity β€” Resume usual daily activities after discharge when feeling well. Arm pain, redness, swelling, headache, fever, nausea, dizziness, fatigue, and muscle aches can occur and generally settle within a few days.
  • Injection-site care β€” Keep the upper arm comfortable and avoid repeated pressure or rubbing if it is sore. Report a progressively worsening local reaction, unusual bruising, or bleeding, especially when using anticoagulants or with a bleeding disorder.
  • Emergency symptoms β€” Seek emergency medical care for hives, facial or throat swelling, breathing difficulty, collapse, severe weakness, or rapidly worsening dizziness. Contact a clinician for persistent high fever or symptoms that do not improve.
  • Series completion and screening β€” Store the detailed vaccination record and arrange remaining doses at the indicated intervals. Continue clinician-recommended cervical screening because Gardasil 9 prevents new vaccine-type disease but does not treat existing HPV-related disease.

Follow the treating doctor’s instructions and contact the clinic promptly when anything appears wrong.

Frequently Asked Questions

Related Blogs

Viveve Laser in Korea: RF Treatment, Safety, Evidence and Travel Planning

Viveve Laser in Korea: RF Treatment, Safety, Evidence and Travel Planning

Viveve is a non-incisional, cryogen-cooled monopolar RF treatmentβ€”not a laserβ€”used in selected patients after gynecologic assessment, with limited evidence for vaginal-laxity symptoms and no established cure for incontinence. International patients considering treatment in Korea can review candidate criteria, MFDS device verification, outpatient recovery, 10-day intercourse and tampon restrictions

Updated: Sep 22, 2026

Adenomyosis in Korea: Diagnosis, Fertility Decisions, and Treatment Options

Adenomyosis in Korea: Diagnosis, Fertility Decisions, and Treatment Options

Adenomyosis care begins with gynecologic assessment, ultrasound or MRI, and treatment selection based on symptoms, anatomy, anemia, and fertility goals. Options include medication, LNG-IUS, HIFU, UAE, adenomyomectomy, or hysterectomy, with travel-stay guidance, recovery planning, warning signs, and follow-up information for international patients.

Updated: Sep 22, 2026

Uterine Fibroids Treatment in Korea: Options, Recovery, Fertility, and Travel Planning

Uterine Fibroids Treatment in Korea: Options, Recovery, Fertility, and Travel Planning

Uterine fibroid treatment includes medication, myomectomy, uterine artery embolization, focused ultrasound or radiofrequency ablation, and hysterectomy based on symptoms, fibroid mapping, and fertility goals. The article outlines candidacy, imaging and travel planning in Korea, recovery timelines, preparation, follow-up, and urgent warning signs.

Updated: Sep 22, 2026

Vaginal Dryness in Korea: Evaluation, GSM Treatment, Travel Planning, and Aftercare

Vaginal Dryness in Korea: Evaluation, GSM Treatment, Travel Planning, and Aftercare

Vaginal dryness care begins with evaluation for menopause-related GSM, infection, skin conditions, pelvic-floor pain, and other causes, followed by lubricants, moisturizers, local estrogen when appropriate, or pelvic-floor support. In Korea, outpatient consultation typically takes 0–2 days with no routine recovery period, while ongoing local-estrogen prescribing and follow-up should be coordinated

Updated: Sep 22, 2026

    Are you a clinic?

    Join our trusted platform to effortlessly enhance your online visibility among those seeking top-quality medical care in Korea from abroad.